Takeda Pharmaceutical Company Limited Takeda (NYSE: TAK) and Evotec Announces Multi-RNA target Alliance Takeda Pharmaceutical Company Limited (NYSE: TAK) has inked an agreement with Evotec SE. Both the firms have made a strategic partnership with the sole aim to discover and create RNA targeting small molecule therapeutics.
Takeda Pharmaceutical Company Limited Takeda (NYSE: TAK) Announces Submission Of NDA For Lanadelumab In Japan Takeda Pharmaceutical Company Limited (NYSE: TAK) declared Friday that it has submitted New Drug Application (NDA) for Lanadelumab to the Ministry of Health, Labour and Welfare (MHLW) in Japan.
Takeda Pharmaceutical Company Limited Takeda (NYSE: TAK) Intends To Gain Approval For Moderna’s COVID19 Vaccine Takeda Pharmaceutical Company Limited (NYSE: TAK) disclosed Friday that it has requested regulators to give authorization for the use of the COVID-19 vaccine of Moderna Inc (NASDAQ: MRNA).
